SURGICAL INNOVATION · LOWER RECTUM ONCOLOGY

Closing the leakage gap.

A purpose-built, single-use instrument for low rectal cancer surgery — engineered to lower anastomotic leakage from 15% to 3%.

THE CLINICAL REALITY

15%

Anastomotic leakage in lower rectum resection today

3%

Target leakage rate with the Avistal instrument

20 YRS

Of surgical insight and pre-clinical work behind the design

THE AVISTAL INSTRUMENT

A single-use device built for the lower rectum — where today's tools fall short.

Twenty years of animal and human trials shaped a final design that fits the anatomy of the low pelvis, supports a reliable anastomosis, and gives surgeons a predictable result in the most demanding part of colorectal oncology.

WHY AVISTAL

Engineered around the surgeon, the patient, and the OR economy.

Lower leakage

Target 3% anastomotic leakage versus today's 15% in low rectum cases.

Anatomy-first

Geometry designed specifically for the narrow lower pelvis.

Single-use safety

Eliminates reprocessing variability between procedures.

OR efficiency

Predictable handling shortens the critical steps of the anastomosis.

RAISING · SEED · 1 MSEK

Join us in rewriting the outcome of low rectal cancer surgery.

TECHNOLOGY

An instrument built for the rectum cancer surgery.

Two decades of animal and human trials shaped a final design that addresses the most failure-prone moment in colorectal cancer surgery.

THE DEVICE

Purpose-built where general instruments fail.

Conventional staplers and clamps were designed for the abdomen, not the narrow confines of the low pelvis. The Avistal device is shaped around the surgical field — improving tissue handling at the precise step where leakage occurs.

• Anatomy-matched working tip for the lower rectum

• Single-use, ready-to-use sterile packaging

• Compatible with standard laparoscopic workflows

• Engineered for reproducible anastomoses


PROCEDURE FLOW

Four predictable steps in the most unpredictable part of the operation.

Access

Designed to reach the deep pelvis without compromising visibility or control.

Align

Anatomy-matched geometry stabilises tissue at the anastomotic site.

Secure

Engineered to deliver a reproducible, low-tension anastomosis.

Withdraw

Single-use removal leaves nothing to reprocess between patients.

EVIDENCE

Built on twenty years of trials.

20+

Years of animal & human study informing the design

1

Single-use device, ready for the OR

5x

Lower leakage targeted vs. today's standard

TEAM

Surgical insight. Founder grit.

Two decades of animal and human trials shaped a final design that addresses the most failure-prone moment in colorectal surgery.

Engineered around the surgeon, the patient, and the OR economy.

Thomas Hellström
FOUNDER

Leads business strategi, communication, organisation, engineering and product development.

Anders Wallenås
FOUNDER

Drives company strategy, fundraising and commercial partnerships across the Nordics.

Lotta Ljunberg

QA/REGULATORY

Leads quality assurance, regulatory compliance, and continuous improvement initiatives, bringing extensive MedTech industry experience across quality systems, audits, and product lifecycle management.

Surgical Experts
CLINICAL ADVISORY

A network of experienced surgeons providing clinical insight and validating device requirements from the operating theatre.

Based in Sweden. Building for surgeons worldwide.

Avistal Nordic AB is headquartered in Sweden and works with clinical partners across the Nordics to validate every iteration of the device against real operating-room demands.

CONTACT

Let´s talk.

Investors, clinical partners, and press are welcome. We respond personally.

SEND MESSAGE

Name Email Organisation Message Skicka in

Scheelevägen 17, 223 63 Lund, Sverige

+46707577814

Söndag: stängt, Måndag-fredag: 8:00-18:00, Lördag: 10:00-16:00